Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.880
+0.090 (1.88%)
Jun 29, 2026, 12:30 PM EDT - Market open
Aardvark Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Aardvark Therapeutics stock have an average target of 13.14, with a low estimate of 3.00 and a high estimate of 45. The average target predicts an increase of 169.26% from the current stock price of 4.88.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for Aardvark Therapeutics stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 8 | 8 | 6 | 6 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +43.44% | May 15, 2026 |
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 15, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 15, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Downgrades $7 → $3 | Sell | Downgrades | $7 → $3 | -38.52% | May 15, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Downgrades $4 | Sell | Downgrades | $4 | -18.03% | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.65
from -2.93
EPS Next Year
-3.24
from -3.65
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.83 | -1.59 | |
| Avg | -3.65 | -3.24 | |
| Low | -4.40 | -5.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.